0001179110-11-011838.txt : 20110808 0001179110-11-011838.hdr.sgml : 20110808 20110808104552 ACCESSION NUMBER: 0001179110-11-011838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110805 FILED AS OF DATE: 20110808 DATE AS OF CHANGE: 20110808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marucci Anthony S CENTRAL INDEX KEY: 0001429933 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 111016008 MAIL ADDRESS: STREET 1: 66 COLD HILL DRIVE CITY: MENDAHM STATE: NJ ZIP: 07945 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0304 4 2011-08-05 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001429933 Marucci Anthony S C/O CELLDEX THERAPEUTICS, INC. 119 FOURTH AVENUE NEEDHAM MA 02494 0 1 0 0 President & CEO Incentive Stock Option 2.80 2011-08-05 4 A 0 180400 2.80 A 2012-08-05 2021-08-05 Common Stock 180400 180400 D 25% vest on August 5, 2012 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Anthony S. Marucci 2011-08-08